Loading…

Regulation of TRIB1 abundance in hepatocyte models in response to proteasome inhibition

Tribbles related homolog 1 (TRIB1) contributes to lipid and glucose homeostasis by facilitating the degradation of cognate cargos by the proteasome. In view of the key metabolic role of TRIB1 and the impact of proteasome inhibition on hepatic function, we continue our exploration of TRIB1 regulation...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2023-06, Vol.13 (1), p.9320-9320, Article 9320
Main Authors: Soubeyrand, Sébastien, Lau, Paulina, McPherson, Ruth
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c541t-f2576b7ff8c26586ffd57ce05818c51febbe4f525dd8348314400c2902b5d1bb3
cites cdi_FETCH-LOGICAL-c541t-f2576b7ff8c26586ffd57ce05818c51febbe4f525dd8348314400c2902b5d1bb3
container_end_page 9320
container_issue 1
container_start_page 9320
container_title Scientific reports
container_volume 13
creator Soubeyrand, Sébastien
Lau, Paulina
McPherson, Ruth
description Tribbles related homolog 1 (TRIB1) contributes to lipid and glucose homeostasis by facilitating the degradation of cognate cargos by the proteasome. In view of the key metabolic role of TRIB1 and the impact of proteasome inhibition on hepatic function, we continue our exploration of TRIB1 regulation in two commonly used human hepatocyte models, transformed cell lines HuH-7 and HepG2. In both models, proteasome inhibitors potently upregulated both endogenous and recombinant TRIB1 mRNA and protein levels. Increased transcript abundance was unaffected by MAPK inhibitors while ER stress was a weaker inducer. Suppressing proteasome function via PSMB3 silencing was sufficient to increase TRIB1 mRNA expression. ATF3 was required to sustain basal TRIB1 expression and support maximal induction. Despite increasing TRIB1 protein abundance and stabilizing bulk ubiquitylation, proteasome inhibition delayed but did not prevent TRIB1 loss upon translation block. Immunoprecipitation experiments indicated that TRIB1 was not ubiquitylated in response to proteasome inhibition. A control bona fide proteasome substrate revealed that high doses of proteasome inhibitors resulted in incomplete proteasome inhibition. Cytoplasm retained TRIB1 was unstable, suggesting that TRIB1 lability is regulated prior to its nuclear import. N-terminal deletion and substitutions were insufficient to stabilize TRIB1. These findings identify transcriptional regulation as a prominent mechanism increasing TRIB1 abundance in transformed hepatocyte cell lines in response to proteasome inhibition and provide evidence of an inhibitor resistant proteasome activity responsible for TRIB1 degradation.
doi_str_mv 10.1038/s41598-023-36512-7
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_87eba89f58c947f49177a8deab6086fc</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_87eba89f58c947f49177a8deab6086fc</doaj_id><sourcerecordid>2825537419</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-f2576b7ff8c26586ffd57ce05818c51febbe4f525dd8348314400c2902b5d1bb3</originalsourceid><addsrcrecordid>eNp9kstu1TAQhiMEolXpC7BAkdiwCfga2ysEFZcjVUKqilhatjM-J0eJHewEqW-P05TSssAbWzP_fGN7_qp6idFbjKh8lxnmSjaI0Ia2HJNGPKlOCWK8IZSQpw_OJ9V5zkdUFieKYfW8OqGCKEy4Oq1-XMF-Gczcx1BHX19f7T7i2tgldCY4qPtQH2Ayc3Q3M9Rj7GDIazBBnmLIUM-xnlKcweQ4rvJDb_sV9qJ65s2Q4fxuP6u-f_50ffG1ufz2ZXfx4bJxnOG58YSL1grvpSMtl633HRcOEJdYOo49WAvMc8K7TlImKWYMIUcUIpZ32Fp6Vu02bhfNUU-pH0260dH0-jYQ016bNPduAC0FWCOV59IpJjxTWAgjOzC2RaWzK6z3G2ta7AidgzAnMzyCPs6E_qD38ZfGiHDEmSqEN3eEFH8ukGc99tnBMJgAccmaSMJa2SIhi_T1P9JjXFIof7WqOKeijKqoyKZyKeacwN_fBiO9-kBvPtDFB_rWB1qUolcP33Ff8mfqRUA3QS6psIf0t_d_sL8BYg6-DA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2825537419</pqid></control><display><type>article</type><title>Regulation of TRIB1 abundance in hepatocyte models in response to proteasome inhibition</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Soubeyrand, Sébastien ; Lau, Paulina ; McPherson, Ruth</creator><creatorcontrib>Soubeyrand, Sébastien ; Lau, Paulina ; McPherson, Ruth</creatorcontrib><description>Tribbles related homolog 1 (TRIB1) contributes to lipid and glucose homeostasis by facilitating the degradation of cognate cargos by the proteasome. In view of the key metabolic role of TRIB1 and the impact of proteasome inhibition on hepatic function, we continue our exploration of TRIB1 regulation in two commonly used human hepatocyte models, transformed cell lines HuH-7 and HepG2. In both models, proteasome inhibitors potently upregulated both endogenous and recombinant TRIB1 mRNA and protein levels. Increased transcript abundance was unaffected by MAPK inhibitors while ER stress was a weaker inducer. Suppressing proteasome function via PSMB3 silencing was sufficient to increase TRIB1 mRNA expression. ATF3 was required to sustain basal TRIB1 expression and support maximal induction. Despite increasing TRIB1 protein abundance and stabilizing bulk ubiquitylation, proteasome inhibition delayed but did not prevent TRIB1 loss upon translation block. Immunoprecipitation experiments indicated that TRIB1 was not ubiquitylated in response to proteasome inhibition. A control bona fide proteasome substrate revealed that high doses of proteasome inhibitors resulted in incomplete proteasome inhibition. Cytoplasm retained TRIB1 was unstable, suggesting that TRIB1 lability is regulated prior to its nuclear import. N-terminal deletion and substitutions were insufficient to stabilize TRIB1. These findings identify transcriptional regulation as a prominent mechanism increasing TRIB1 abundance in transformed hepatocyte cell lines in response to proteasome inhibition and provide evidence of an inhibitor resistant proteasome activity responsible for TRIB1 degradation.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-023-36512-7</identifier><identifier>PMID: 37291259</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/45 ; 631/67 ; 631/80 ; Activating transcription factor 3 ; Antibodies ; Cell culture ; Cell lines ; Cytoplasm ; Gene expression ; Gene regulation ; Hepatocytes - metabolism ; Homeostasis ; Humanities and Social Sciences ; Humans ; Immunoprecipitation ; Inhibition ; Inhibitors ; Intracellular Signaling Peptides and Proteins - genetics ; Intracellular Signaling Peptides and Proteins - metabolism ; Lability ; Liver ; MAP kinase ; multidisciplinary ; Nuclear transport ; Proteasome Endopeptidase Complex - metabolism ; Proteasome inhibitors ; Proteasome Inhibitors - metabolism ; Proteasome Inhibitors - pharmacology ; Proteasomes ; Protein Serine-Threonine Kinases - metabolism ; Proteins ; RNA, Messenger - genetics ; Science ; Science (multidisciplinary) ; Ubiquitin</subject><ispartof>Scientific reports, 2023-06, Vol.13 (1), p.9320-9320, Article 9320</ispartof><rights>The Author(s) 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-f2576b7ff8c26586ffd57ce05818c51febbe4f525dd8348314400c2902b5d1bb3</citedby><cites>FETCH-LOGICAL-c541t-f2576b7ff8c26586ffd57ce05818c51febbe4f525dd8348314400c2902b5d1bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2825537419/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2825537419?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37291259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soubeyrand, Sébastien</creatorcontrib><creatorcontrib>Lau, Paulina</creatorcontrib><creatorcontrib>McPherson, Ruth</creatorcontrib><title>Regulation of TRIB1 abundance in hepatocyte models in response to proteasome inhibition</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Tribbles related homolog 1 (TRIB1) contributes to lipid and glucose homeostasis by facilitating the degradation of cognate cargos by the proteasome. In view of the key metabolic role of TRIB1 and the impact of proteasome inhibition on hepatic function, we continue our exploration of TRIB1 regulation in two commonly used human hepatocyte models, transformed cell lines HuH-7 and HepG2. In both models, proteasome inhibitors potently upregulated both endogenous and recombinant TRIB1 mRNA and protein levels. Increased transcript abundance was unaffected by MAPK inhibitors while ER stress was a weaker inducer. Suppressing proteasome function via PSMB3 silencing was sufficient to increase TRIB1 mRNA expression. ATF3 was required to sustain basal TRIB1 expression and support maximal induction. Despite increasing TRIB1 protein abundance and stabilizing bulk ubiquitylation, proteasome inhibition delayed but did not prevent TRIB1 loss upon translation block. Immunoprecipitation experiments indicated that TRIB1 was not ubiquitylated in response to proteasome inhibition. A control bona fide proteasome substrate revealed that high doses of proteasome inhibitors resulted in incomplete proteasome inhibition. Cytoplasm retained TRIB1 was unstable, suggesting that TRIB1 lability is regulated prior to its nuclear import. N-terminal deletion and substitutions were insufficient to stabilize TRIB1. These findings identify transcriptional regulation as a prominent mechanism increasing TRIB1 abundance in transformed hepatocyte cell lines in response to proteasome inhibition and provide evidence of an inhibitor resistant proteasome activity responsible for TRIB1 degradation.</description><subject>631/45</subject><subject>631/67</subject><subject>631/80</subject><subject>Activating transcription factor 3</subject><subject>Antibodies</subject><subject>Cell culture</subject><subject>Cell lines</subject><subject>Cytoplasm</subject><subject>Gene expression</subject><subject>Gene regulation</subject><subject>Hepatocytes - metabolism</subject><subject>Homeostasis</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Immunoprecipitation</subject><subject>Inhibition</subject><subject>Inhibitors</subject><subject>Intracellular Signaling Peptides and Proteins - genetics</subject><subject>Intracellular Signaling Peptides and Proteins - metabolism</subject><subject>Lability</subject><subject>Liver</subject><subject>MAP kinase</subject><subject>multidisciplinary</subject><subject>Nuclear transport</subject><subject>Proteasome Endopeptidase Complex - metabolism</subject><subject>Proteasome inhibitors</subject><subject>Proteasome Inhibitors - metabolism</subject><subject>Proteasome Inhibitors - pharmacology</subject><subject>Proteasomes</subject><subject>Protein Serine-Threonine Kinases - metabolism</subject><subject>Proteins</subject><subject>RNA, Messenger - genetics</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Ubiquitin</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kstu1TAQhiMEolXpC7BAkdiwCfga2ysEFZcjVUKqilhatjM-J0eJHewEqW-P05TSssAbWzP_fGN7_qp6idFbjKh8lxnmSjaI0Ia2HJNGPKlOCWK8IZSQpw_OJ9V5zkdUFieKYfW8OqGCKEy4Oq1-XMF-Gczcx1BHX19f7T7i2tgldCY4qPtQH2Ayc3Q3M9Rj7GDIazBBnmLIUM-xnlKcweQ4rvJDb_sV9qJ65s2Q4fxuP6u-f_50ffG1ufz2ZXfx4bJxnOG58YSL1grvpSMtl633HRcOEJdYOo49WAvMc8K7TlImKWYMIUcUIpZ32Fp6Vu02bhfNUU-pH0260dH0-jYQ016bNPduAC0FWCOV59IpJjxTWAgjOzC2RaWzK6z3G2ta7AidgzAnMzyCPs6E_qD38ZfGiHDEmSqEN3eEFH8ukGc99tnBMJgAccmaSMJa2SIhi_T1P9JjXFIof7WqOKeijKqoyKZyKeacwN_fBiO9-kBvPtDFB_rWB1qUolcP33Ff8mfqRUA3QS6psIf0t_d_sL8BYg6-DA</recordid><startdate>20230608</startdate><enddate>20230608</enddate><creator>Soubeyrand, Sébastien</creator><creator>Lau, Paulina</creator><creator>McPherson, Ruth</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230608</creationdate><title>Regulation of TRIB1 abundance in hepatocyte models in response to proteasome inhibition</title><author>Soubeyrand, Sébastien ; Lau, Paulina ; McPherson, Ruth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-f2576b7ff8c26586ffd57ce05818c51febbe4f525dd8348314400c2902b5d1bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>631/45</topic><topic>631/67</topic><topic>631/80</topic><topic>Activating transcription factor 3</topic><topic>Antibodies</topic><topic>Cell culture</topic><topic>Cell lines</topic><topic>Cytoplasm</topic><topic>Gene expression</topic><topic>Gene regulation</topic><topic>Hepatocytes - metabolism</topic><topic>Homeostasis</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Immunoprecipitation</topic><topic>Inhibition</topic><topic>Inhibitors</topic><topic>Intracellular Signaling Peptides and Proteins - genetics</topic><topic>Intracellular Signaling Peptides and Proteins - metabolism</topic><topic>Lability</topic><topic>Liver</topic><topic>MAP kinase</topic><topic>multidisciplinary</topic><topic>Nuclear transport</topic><topic>Proteasome Endopeptidase Complex - metabolism</topic><topic>Proteasome inhibitors</topic><topic>Proteasome Inhibitors - metabolism</topic><topic>Proteasome Inhibitors - pharmacology</topic><topic>Proteasomes</topic><topic>Protein Serine-Threonine Kinases - metabolism</topic><topic>Proteins</topic><topic>RNA, Messenger - genetics</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Ubiquitin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soubeyrand, Sébastien</creatorcontrib><creatorcontrib>Lau, Paulina</creatorcontrib><creatorcontrib>McPherson, Ruth</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soubeyrand, Sébastien</au><au>Lau, Paulina</au><au>McPherson, Ruth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of TRIB1 abundance in hepatocyte models in response to proteasome inhibition</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2023-06-08</date><risdate>2023</risdate><volume>13</volume><issue>1</issue><spage>9320</spage><epage>9320</epage><pages>9320-9320</pages><artnum>9320</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Tribbles related homolog 1 (TRIB1) contributes to lipid and glucose homeostasis by facilitating the degradation of cognate cargos by the proteasome. In view of the key metabolic role of TRIB1 and the impact of proteasome inhibition on hepatic function, we continue our exploration of TRIB1 regulation in two commonly used human hepatocyte models, transformed cell lines HuH-7 and HepG2. In both models, proteasome inhibitors potently upregulated both endogenous and recombinant TRIB1 mRNA and protein levels. Increased transcript abundance was unaffected by MAPK inhibitors while ER stress was a weaker inducer. Suppressing proteasome function via PSMB3 silencing was sufficient to increase TRIB1 mRNA expression. ATF3 was required to sustain basal TRIB1 expression and support maximal induction. Despite increasing TRIB1 protein abundance and stabilizing bulk ubiquitylation, proteasome inhibition delayed but did not prevent TRIB1 loss upon translation block. Immunoprecipitation experiments indicated that TRIB1 was not ubiquitylated in response to proteasome inhibition. A control bona fide proteasome substrate revealed that high doses of proteasome inhibitors resulted in incomplete proteasome inhibition. Cytoplasm retained TRIB1 was unstable, suggesting that TRIB1 lability is regulated prior to its nuclear import. N-terminal deletion and substitutions were insufficient to stabilize TRIB1. These findings identify transcriptional regulation as a prominent mechanism increasing TRIB1 abundance in transformed hepatocyte cell lines in response to proteasome inhibition and provide evidence of an inhibitor resistant proteasome activity responsible for TRIB1 degradation.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>37291259</pmid><doi>10.1038/s41598-023-36512-7</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2023-06, Vol.13 (1), p.9320-9320, Article 9320
issn 2045-2322
2045-2322
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_87eba89f58c947f49177a8deab6086fc
source Open Access: PubMed Central; Publicly Available Content Database; Free Full-Text Journals in Chemistry; Springer Nature - nature.com Journals - Fully Open Access
subjects 631/45
631/67
631/80
Activating transcription factor 3
Antibodies
Cell culture
Cell lines
Cytoplasm
Gene expression
Gene regulation
Hepatocytes - metabolism
Homeostasis
Humanities and Social Sciences
Humans
Immunoprecipitation
Inhibition
Inhibitors
Intracellular Signaling Peptides and Proteins - genetics
Intracellular Signaling Peptides and Proteins - metabolism
Lability
Liver
MAP kinase
multidisciplinary
Nuclear transport
Proteasome Endopeptidase Complex - metabolism
Proteasome inhibitors
Proteasome Inhibitors - metabolism
Proteasome Inhibitors - pharmacology
Proteasomes
Protein Serine-Threonine Kinases - metabolism
Proteins
RNA, Messenger - genetics
Science
Science (multidisciplinary)
Ubiquitin
title Regulation of TRIB1 abundance in hepatocyte models in response to proteasome inhibition
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A58%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20TRIB1%20abundance%20in%20hepatocyte%20models%20in%20response%20to%20proteasome%20inhibition&rft.jtitle=Scientific%20reports&rft.au=Soubeyrand,%20S%C3%A9bastien&rft.date=2023-06-08&rft.volume=13&rft.issue=1&rft.spage=9320&rft.epage=9320&rft.pages=9320-9320&rft.artnum=9320&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-023-36512-7&rft_dat=%3Cproquest_doaj_%3E2825537419%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c541t-f2576b7ff8c26586ffd57ce05818c51febbe4f525dd8348314400c2902b5d1bb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2825537419&rft_id=info:pmid/37291259&rfr_iscdi=true